Breaking News Instant updates and real-time market news.

ICPT

Intercept

$118.02

3.76 (3.29%)

07:39
12/17/19
12/17
07:39
12/17/19
07:39

Intercept price target raised to $146 from $120 at Wells Fargo

Wells Fargo analyst Jim Birchenough raised his price target for Intercept to $146 from $120 and reiterated an Overweight rating following the company's NASH commercial day and on prospects for significant market opportunity for obeticholic acid in patients with NASH and advanced fibrosis. The analyst tells investors in a research note that he continues to believe that adoption of non-invasive testing remains a key value driver for Intercept and is encouraged by positive key opinion leader feedback.

  • 26

    Mar

ICPT Intercept
$118.02

3.76 (3.29%)

11/25/19
STFL
11/25/19
NO CHANGE
Target $102
STFL
Hold
Intercept price target raised to $102 from $86 at Stifel
Stifel analyst Derek Archila raised his price target for Intercept Pharmaceuticals (ICPT) to $102 from $86 after the FDA accepted OCA's new drug application for nonalcoholic steatohepatitis and granted it a priority review. The stock in midday trading is up 10.5% to $98.24. The FDA plans to hold a panel meeting, which is in-line with expectations, Archila tells investors in a research note. In addition, CymaBay (CBAY) terminating its Phase 2b study in NASH due to atypical histology findings and halting its studies for seladelpar in primary biliary cirrhosis means Intercept will likely have one less competitor in NASH but more importantly, one less in PBC, says the analyst. He thinks CymaBay's issues are a positive development for Intercept's PBC franchise but keeps a Hold rating on the shares.
11/26/19
WEDB
11/26/19
NO CHANGE
Target $257
WEDB
Outperform
Intercept price target raised to $257 from $243 at Wedbush
Wedbush analyst Liana Moussatos raised her price target for Intercept Pharmaceuticals to $257 from $243 after the FDA accepted the company's new drug application of obeticholic acid for the treatment of fibrosis due to nonalcoholic steatohepatitis and granted priority review. The analyst anticipates a positive FDA panel vote and approval for OCA. She projects potential achievement of blockbuster, or over $1B, revenue in 2024 after a potential U.S. launch in October 2020. Moussatos keeps an Overweight rating on shares of Intercept.
11/26/19
HCWC
11/26/19
NO CHANGE
HCWC
Favorable safety a positive for Genfit's elafibranor, says H.C. Wainwright
After Genfit (GNFT) this morning announced that the Data Safety Monitoring Board issued a positive recommendation for the continuation, without any modifications, of the Resole-It Phase 3 trial evaluating elafibranor in nonalcoholic steatohepatitis, H.C. Wainwright analyst Ed Arce noted this is the seventh such report affirming the favorable safety profile of elafibranor. After CymaBay (CBAY) announced yesterday that it has halted all clinical development of its lead drug seladelpar, Arce also noted that there have been no cases of interface hepatitis seen in all trials to date with elafibranor. "One less competitor only benefits the other players in the space, and the two remaining PPARs, especially elafibranor," added Arce. Commenting further on Intercept's (ICPT) announcement yesterday that the FDA has accepted its NDA for obeticholic acid for accelerated approval for the treatment of fibrosis due to NASH, Arce said he sees "two very differentiated profiles with the first two drugs likely to be approved for NASH," namely Intercept's OCA and Genfit's elafibranor. The analyst, who concludes with the assertion that the "overall efficacy, safety and tolerability profile of elafibranor is hands down superior to that of OCA," keeps a Buy rating and $58 price target on Genfit shares.
12/02/19
ADAM
12/02/19
INITIATION
Target $165
ADAM
Buy
Intercept initiated with a Buy at Canaccord
Canaccord analyst Edward Nash initiated coverage of Intercept with a Buy rating and $165 price target.

TODAY'S FREE FLY STORIES

CCC

Clarivate Analytics

$18.90

1.24 (7.02%)

21:43
01/20/20
01/20
21:43
01/20/20
21:43
Upgrade
Clarivate Analytics rating change  »

Clarivate Analytics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

CCC

Clarivate Analytics

$18.90

1.24 (7.02%)

21:42
01/20/20
01/20
21:42
01/20/20
21:42
Hot Stocks
Clarivate Analytics acquires Decision Resources Group for $950M »

Clarivate Analytics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

BA

Boeing

$324.11

-7.89 (-2.38%)

20:05
01/20/20
01/20
20:05
01/20/20
20:05
Periodicals
Air Niugini delaying delivery of four 737 MAX jets, Reuters reports »

Papua New Guinea carrier…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jan

AVASF

Avast

$0.00

(0.00%)

20:01
01/20/20
01/20
20:01
01/20/20
20:01
Recommendations
Avast analyst commentary at Jefferies »

Avast set to deliver…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NFLX

Netflix

$339.56

0.89 (0.26%)

, CMCSK

Comcast

$0.00

(0.00%)

19:55
01/20/20
01/20
19:55
01/20/20
19:55
Hot Stocks
Fly Intel: Top five weekend stock stories »

Catch up on the…

NFLX

Netflix

$339.56

0.89 (0.26%)

CMCSK

Comcast

$0.00

(0.00%)

CMCSA

Comcast

$47.48

0.62 (1.32%)

TSLA

Tesla

$510.34

-3.065 (-0.60%)

BA

Boeing

$324.11

-7.89 (-2.38%)

GOOG

Alphabet

$1,480.28

28.34 (1.95%)

GOOGL

Alphabet Class A

$1,479.12

29.29 (2.02%)

SNE

Sony

$72.48

-0.07 (-0.10%)

KKR

KKR

$31.20

0.7 (2.30%)

TSM

TSMC

$58.58

-0.18 (-0.31%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jan

  • 22

    Jan

  • 23

    Jan

  • 29

    Jan

  • 29

    Jan

  • 31

    Jan

  • 03

    Feb

  • 03

    Feb

  • 04

    Feb

  • 10

    Feb

  • 24

    Feb

  • 26

    Feb

  • 23

    Mar

  • 23

    Mar

HD

Home Depot

$231.90

3.07 (1.34%)

18:06
01/20/20
01/20
18:06
01/20/20
18:06
Periodicals
Mexican trade union suspends strike threat against Home Depot, Reuters says »

A top Mexican trade union…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

UCFC

United Community Financial

$11.56

-0.02 (-0.17%)

, FDEF

First Defiance Financial

$31.12

-0.1 (-0.32%)

18:00
01/20/20
01/20
18:00
01/20/20
18:00
Hot Stocks
First Defiance Financial receives approval for United Community Financial merger »

First Defiance Financial…

UCFC

United Community Financial

$11.56

-0.02 (-0.17%)

FDEF

First Defiance Financial

$31.12

-0.1 (-0.32%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jan

FDEF

First Defiance Financial

$31.12

-0.1 (-0.32%)

17:56
01/20/20
01/20
17:56
01/20/20
17:56
Earnings
Breaking Earnings news story on First Defiance Financial »

First Defiance Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jan

T

AT&T

$38.36

0.33 (0.87%)

, CMCSA

Comcast

$47.48

0.62 (1.32%)

17:37
01/20/20
01/20
17:37
01/20/20
17:37
On The Fly
Box Office Battle: 'Bad Boys for Life' wins MLK Jr. weekend with $73M debut »

"Box Office Battle" is…

T

AT&T

$38.36

0.33 (0.87%)

CMCSA

Comcast

$47.48

0.62 (1.32%)

CMCSK

Comcast

$0.00

(0.00%)

SNE

Sony

$72.48

-0.07 (-0.10%)

LGF.A

Lionsgate

$10.96

-0.32 (-2.84%)

LGF.B

Lionsgate

$10.32

-0.305 (-2.87%)

DIS

Disney

$144.25

-0.85 (-0.59%)

VIACA

ViacomCBS

$43.26

-0.855 (-1.94%)

VIAC

ViacomCBS

$39.48

-0.57 (-1.42%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 29

    Jan

  • 04

    Feb

  • 04

    Feb

  • 06

    Feb

  • 06

    Feb

STIM

Neuronetics

$4.38

-0.01 (-0.23%)

17:00
01/20/20
01/20
17:00
01/20/20
17:00
Recommendations
Neuronetics analyst commentary at Piper Sandler »

Correction in Neuronetics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TCMD

Tactile Systems

$60.76

-2.74 (-4.31%)

16:55
01/20/20
01/20
16:55
01/20/20
16:55
Recommendations
Tactile Systems analyst commentary at Piper Sandler »

Lawsuit may drag out into…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EFSC

Enterprise Financial

$48.49

0.16 (0.33%)

16:45
01/20/20
01/20
16:45
01/20/20
16:45
Earnings
Enterprise Financial reports Q4 EPS $1.09, consensus $1.09 »

Reports Q4 net interest…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jan

TGP

Teekay LNG

$14.73

-0.26 (-1.73%)

16:33
01/20/20
01/20
16:33
01/20/20
16:33
Hot Stocks
Teekay LNG Partners declares distribution of 19c per common unit »

Teekay GP, the general…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WES

Western Midstream

$20.60

-0.55 (-2.60%)

16:31
01/20/20
01/20
16:31
01/20/20
16:31
Hot Stocks
Western Midstream announces Q4 2019 distribution »

Western Midstream…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

CPG

Crescent Point Energy

$4.20

-0.08 (-1.87%)

16:29
01/20/20
01/20
16:29
01/20/20
16:29
Hot Stocks
Crescent Point closes sale of gas infrastructure assets »

Crescent Point announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CHSCP

CHS Inc.

$28.85

0.13 (0.45%)

16:26
01/20/20
01/20
16:26
01/20/20
16:26
Hot Stocks
CHS Inc. names Olivia Nelligan as Chief Financial Officer »

CHS Inc. announced it has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GMAB

Genmab

$22.73

-0.13 (-0.57%)

, JNJ

Johnson & Johnson

$149.07

0.82 (0.55%)

16:25
01/20/20
01/20
16:25
01/20/20
16:25
Hot Stocks
Genmab announces European Marketing Authorization for DARZALEX »

Genmab A/S (GMAB)…

GMAB

Genmab

$22.73

-0.13 (-0.57%)

JNJ

Johnson & Johnson

$149.07

0.82 (0.55%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 09

    Mar

  • 17

    Mar

PRPO

Precipio

$2.09

-0.02 (-0.95%)

16:25
01/20/20
01/20
16:25
01/20/20
16:25
Conference/Events
Precipio to host shareholder update conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jan

TILE

Interface

$17.37

0.23 (1.34%)

16:22
01/20/20
01/20
16:22
01/20/20
16:22
Hot Stocks
Interface names Dan Hendrix as President, CEO »

Interface announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IBCP

Independent Bank

$22.51

-0.26 (-1.14%)

16:19
01/20/20
01/20
16:19
01/20/20
16:19
Hot Stocks
Independent Bank announces 11% increase in quarterly cash dividend »

Independent Bank…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 18

    Feb

  • 19

    Feb

JAZZ

Jazz Pharmaceuticals

$151.00

-0.56 (-0.37%)

16:17
01/20/20
01/20
16:17
01/20/20
16:17
Hot Stocks
Jazz Pharmaceuticals receives EU Marketing Authorization for Sunosi »

Jazz Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jan

AMRN

Amarin

$19.91

-0.15 (-0.75%)

16:13
01/20/20
01/20
16:13
01/20/20
16:13
Recommendations
Amarin analyst commentary at Jefferies »

Amarin remains in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPY

SPDR S&P 500 ETF Trust

$331.98

1.08 (0.33%)

, SPX

S&P 500

$0.00

(0.00%)

16:09
01/20/20
01/20
16:09
01/20/20
16:09
Periodicals
Macron, Trump declare truce in digital tax dispute, Reuters reports »

French President Emmanuel…

SPY

SPDR S&P 500 ETF Trust

$331.98

1.08 (0.33%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XOM

Exxon Mobil

$68.55

-0.26 (-0.38%)

, HES

Hess Corp.

$69.87

-0.45 (-0.64%)

16:07
01/20/20
01/20
16:07
01/20/20
16:07
Periodicals
Guyana's first oil cargo to be refined by Exxon in the U.S., Reuters reports »

A vessel carrying…

XOM

Exxon Mobil

$68.55

-0.26 (-0.38%)

HES

Hess Corp.

$69.87

-0.45 (-0.64%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jan

  • 31

    Jan

  • 23

    Mar

TSLA

Tesla

$510.34

-3.065 (-0.60%)

16:04
01/20/20
01/20
16:04
01/20/20
16:04
Periodicals
Tesla rebuffs U.S. safety recall petition, Reuters reports »

Tesla said there was no…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jan

  • 24

    Feb

  • 23

    Mar

  • 23

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.